Investigation of the relationship between demographic characteristics and frequency of mortality in certain cases of influenza A (H1N1) from Yazd province (Iran)

Jundishapur Journal of Microbiology

Volumn 6, Issue 10, 2013, Pages

  Ayatollahi, Jamshid ^a   Golestan, Motahare ^a   Sharif, Mohammad Reza ^a   Esform, Elham ^a   Shahcheraghi, Seyed Hossein ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Demographic; Influenza A (H1N1); Mortality

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHILD; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; GENDER; HEART DISEASE; HEMATOLOGIC DISEASE; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; INFLUENZA A (H1N1); IRAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MENTAL DEFICIENCY; MORTALITY; PREGNANCY; STATISTICAL SIGNIFICANCE; VERY ELDERLY;

EID: 84891499870     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.7472     Document Type: Article

References (21)

1. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, Bestebroer TM, et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science. 2009;325(5939):481-3.
2. Pasma T, Joseph T. Pandemic (H1N1) 2009 infection in swine herds, Manitoba, Canada. Emerg Infect Dis. 2010;16(4):706-8.
3. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen v V, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med. 2004;350(12):1179-88.
4. Belser JA, Wadford DA, Pappas C, Gustin KM, Maines TR, Pearce MB, et al. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J Virol. 2010;84(9):4194-203.
5. Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med. 2000;51:407-21.
6. Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis. 2006;194 Suppl 2:S82-91.
7. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361(7):680-9.
8. Szilagyi PG, Fairbrother G, Grifn MR, Hornung RW, Donauer S, Morrow A, et al. Influenza vaccine efectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Arch Pediatr Adolesc Med. 2008;162(10):943-51
9. Martin SS, Hollingsworth CL, Norfolk SG, Wolfe CR, Holling-sworth JW. Reversible cardiac dysfunction associated with pandemic 2009 influenza A(H1N1). Chest. 2010;137(5):1195-7
10. Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, Sprung C, et al. Use of early corticosteroid therapy on ICU admission in patients afected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med. 2011;37(2):272-83.
11. Gordova SM. Update: Novel Influenza A (H1N1) Virus Infection ---Mexico, March--May, 2009. Morb Mortal Wkly Rep. 2009;58(21):585-589.
12. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adju-vanted vaccine. N Engl J Med. 2009;361(25):2424-35.
13. De Clercq E. Antiviral drugs in current clinical use. J Clin Virol. 2004;30(2):115-33.
14. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Ben-net J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med. 2009;361(25):2405-13.
15. Liang Xiao-Feng, Wang Hua-Qing, Wang Jun-Zhi, Fang Han-Hua, Wu Jiang, Zhu Feng-Cai, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicen-tre, double-blind, randomised, placebo-controlled trial. The Lancet. 2010;375(9708):56-66.
16. Plennevaux Eric, Sheldon Eric, Blatter Mark, Reeves-Hoché Mary-Kate, Denis Martine. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. The Lancet. 2010;375(9708):41-48.
17. Vajo Zoltan, Tamas Ferenc, Sinka Laszlo, Jankovics Istvan. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. The Lancet. 2010;375(9708):49-55.
18. Echevarria-Zuno S, Mejia-Arangure JM, Mar-Obeso AJ, Grajales-Muniz C, Robles-Perez E, Gonzalez-Leon M, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet. 2009;374(9707):2072-9.
19. Hughes James M, Wilson Mary E, Lee Ellen H, Wu Charles, Lee Elsie U, Stoute Alaina, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis. 2010;50(11):1498-1504.
20. Feng L, Shay DK, Jiang Y, Zhou H, Chen X, Zheng Y, et al. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ. 2012;90(4):279-288B.
21. Camargo Clarice, Guatura Sandra Baltazar, Bellei Nancy. Respiratory viral coinfection among hospitalized patients with H1N1 2009 during the first pandemic wave in Brazil. Brazil J Infec Dis. 2012;16(2):180-183.